Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (39 ops.)
Latest filing published 11 Sept 2026 for Madrigal Pharmaceuticals, INC., €59k. Read the official filing
Filing timeline
BuySaleWilliam John Sibold
Insider track record
Disclosed buys
0
Disclosed sells
39
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
William John Sibold: trading record in brief
William John Sibold, listed as chief executive, appears in our data through filings on Madrigal Pharmaceuticals, Inc. shares, published by SEC (Form 4). In total, 46 filings cover trades dated from 11 September 2023 to 11 September 2026.
The open-market record consists of 39 sales worth €14.1M, with no purchase. Besides market trades, the filings include 4 share grants and 3 option exercises. In 2026 alone, the filings show no purchases and 35 sales.
On 11 September 2026 came the latest disclosure, an open-market sale for €59k in Madrigal Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to William John Sibold
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations46 total
131 shares@ US$527.8783Common StockSEC:0001628280-26-061581:0
347 shares@ US$529.2671Common StockSEC:0001628280-26-061581:1
522 shares@ US$530.2311Common StockSEC:0001628280-26-061581:2
368 shares@ US$531.9897Common StockSEC:0001628280-26-061581:3
512 shares@ US$533.0932Common StockSEC:0001628280-26-061581:4
396 shares@ US$534.1964Common StockSEC:0001628280-26-061581:5
644 shares@ US$535.2719Common StockSEC:0001628280-26-061581:6
1,040 shares@ US$536.1123Common StockSEC:0001628280-26-061581:7
640 shares@ US$537.1738Common StockSEC:0001628280-26-061581:8
520 shares@ US$538.2971Common StockSEC:0001628280-26-061581:9
215 shares@ US$539.0281Common StockSEC:0001628280-26-061581:10
505 shares@ US$540.1909Common StockSEC:0001628280-26-061581:11
362 shares@ US$541.6538Common StockSEC:0001628280-26-061581:12
160 shares@ US$542.5475Common StockSEC:0001628280-26-061581:13
60 shares@ US$533.0913Common StockSEC:0001628280-26-061581:14
106 shares@ US$534.063Common StockSEC:0001628280-26-061581:15
218 shares@ US$535.9435Common StockSEC:0001628280-26-061581:16
160 shares@ US$537.6175Common StockSEC:0001628280-26-061581:17
687 shares@ US$540.5857Common StockSEC:0001628280-26-061581:18
368 shares@ US$541.6423Common StockSEC:0001628280-26-061581:19
1,202 shares@ US$542.6032Common StockSEC:0001628280-26-061581:20
1,539 shares@ US$544.024Common StockSEC:0001628280-26-061581:21
761 shares@ US$544.8307Common StockSEC:0001628280-26-061581:22
120 shares@ US$546.3767Common StockSEC:0001628280-26-061581:23
1 shares@ US$550.720.0000% mcap0.0% of flowCommon StockSEC:0001628280-26-048919:9
25 of 46 declarations
